Publications
Explore all of Natalia Rivera's scientific contributions on her ORCID record or Web of Science ResearcherID with a few special highlights listed below!
A State-Of-The-Art Review.
Miedema JR, Bonella F, Buschulte K, Culver DA, Jeny F, Obi ON, Rivera NV, Spagnolo P, Veltkamp M, Wijsenbeek M. Sarcoidosis: Eur Respir J. 2025 Nov 13:2501324. doi: 10.1183/13993003.01324-2025. PMID: 41232941. Publication link
Genetics in Sarcoidosis and Its Burden as a Multisystem Disease.
Rivera NV, Eklund A. Semin Respir Crit Care Med. 2025 Nov 24. doi: 10.1055/a-2741-2120. PMID: 41285390. Publication link
From Genes to Granulomas: The Role of Genetics in Sarcoidosis.
Petrek M, Rivera NV.Curr Opin Immunol. 2025 Sep 19;97:102663. doi: 10.1016/j.coi.2025.102663. PMID: 40974839. Publication link
Sarcoidosis in the Genomic Era: From Genetic Drivers to Tailored Therapies.
Rivera NV and Israël-Biet D. Curr Allergy Asthma Rep. 2025 Sep;25(1):42. doi: 10.1007/s11882-025-01222-9. PMID: 41026325. Publication link
Unraveling Genetics in Sarcoidosis: Next Steps.
Rivera NV. Editorial, Archivos de Bronconeumología, 2025 April. 26:S0300-2896(25)00150-4. doi: 10.1016/j.arbres.2025.04.014. Publication link
WASOG 2023 conference highlights. Sarcoidosis.
Chuquimia OD, Rivera NV. Vasc Diffuse Lung Dis. 2024 Sept; 41(3):e2024045. doi: 10.36141/svdld.v41i3.16196. PMID: 39315972. Publication link
Unraveling genetic mysteries: phenotype-shaping profiles in chronic sarcoidosis (preprint)
Kullberg S, Darlington P, Ellinghaus D, Prasse A, Iseda T, Chuquimia O, Eklund A, Schreiber S, Müller-Quernheim J, Kockum, Wheelock ÅM, Padyukov L, Mirsaeidi MS, Spagnolo P, Rivera NV. MedRxiv 2024.12.29.24319750; doi:10.1101/2024.12.29.24319750. Publication link
Big data in sarcoidosis.
Rivera NV. Curr Opin Pulm Med. 2024 Jul. doi: 10.1097/MCP.0000000000001102. PMID: 38967053. Publication link
Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types
Abo Al Hayja M, Kullberg S, Eklund A, Padyukov L, Grunewald J, Rivera NV. Front Med (Lausanne). 2023 Feb 7;10:1061654. doi: 10.3389/fmed.2023.1061654. PMID: 36824606; Publication link
Genetic variants associated with sarcoidosis are likely to modulate quantitative levels of BAL cell types and may regulate gene expression in immune cell populations. Thus, the role of sarcoidosis-associated gene variants may be to influence cellular phenotypes underlying the disease immunopathology.
Sex differences in the genetics of sarcoidosis across European and African ancestry populations
Xiong Y, Kullberg S, Garman L, Pezant N, Ellinghaus D, Vasila V, Eklund A, Rybicki BA, Iannuzzi MC, Schreiber S, Müller-Quernheim J, Montgomery CG, Grunewald J, Padyukov L, Rivera NV. Front Med (Lausanne). 2023 May 11;10:1132799. doi: 10.3389/fmed.2023.1132799. PMID: 37250650. Publication link
Sex differences in the susceptibility to sarcoidosis are unknown. The study aimed to identify sex-dependent genetic variations in two clinical sarcoidosis phenotypes: Löfgren's syndrome (LS) and non-Löfgren's syndrome (non-LS). The findings of this study provided new evidence of a sex bias underlying the genetic architecture of sarcoidosis, particularly in the clinical phenotypes LS and non-LS. Biological sex likely plays a role in disease mechanisms in sarcoidosis.
A Gene-Environment Interaction Between Smoking and Gene Polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis
Rivera NV, Patasova K, Kullberg S, Diaz-Gallo LM, Iseda T, Bengtsson C, Alfredsson L, Eklund A, Kockum I, Grunewald J, Padyukov L. Sci Rep. 2019 Dec 9;9(1):18633. doi: 10.1038/s41598-019-54612-1. PMID: 31819081. Publiation link
The findings in this study suggest that sarcoidosis risk is modulated by smoking due to genetic susceptibility. Therefore, patients having certain gene variants, are at a higher risk for the disease. Consideration of an individual's genetic predisposition is crucial to quantify the effects of smoking in sarcoidosis.
Common variants of T-cells contribute differently to phenotypic variation in sarcoidosis
Rivera NV, Hagemann-Jensen M, Ferreira MAR, Kullberg S, Eklund A, Martin NG, Padyukov L, Grunewald J. Sci Rep. 2017 Jul 17;7(1):5623. doi: 10.1038/s41598-017-05754-7. PMID: 28717140. Publication link
Differences in significant polygenic scores, presence of pleiotropy, and distinct genetic factors provide further insights on how genetic variants and genes associated with relative levels of T-cell subtypes contribute differently to sarcoidosis phenotypes.
High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences
Rivera NV, Ronninger M, Shchetynsky K, Franke A, Nöthen MM, Müller-Quernheim J, Schreiber S, Adrianto I, Karakaya B, van Moorsel CH, Navratilova Z, Kolek V, Rybicki BA, Iannuzzi MC, Petrek M, Grutters JC, Montgomery C, Fischer A, Eklund A, Padyukov L, Grunewald J. Am J Respir Crit Care Med. 2016 May 1;193(9):1008-22. doi: 10.1164/rccm.201507-1372OC. PMID:26651848. Publication link
Genetic investigations of sarcoidosis sub-phenotypes: Lofgren syndrome (LS) and Non-Lofgren syndrome (non-LS) – revealed that these sub-phenotypes have their own genetic architecture with a common genomic overlap located on the extended major histocompatibility complex (MHC) region.
Recent advances in sarcoidosis genomics: epigenetics, gene expression, and gene-by-environment (G × E) interaction studies.
Garman L, Montgomery CG, Rivera NV. Curr Opin Pulm Med. 2020 Sep;26(5):544-553. doi: 10.1097/MCP.0000000000000719. PMID: 32701681. Publication link